IRMD - IRADIMED CORP

QQQ $ 481.15 $ 6.24 (1.31 %)

DIA $ 409.09 $ 2.37 (0.58 %)

SPY $ 559.11 $ 5.30 (0.96 %)

TLT $ 97.90 $ 0.45 (0.46 %)

GLD $ 231.62 $ -0.38 (-0.16 %)

Previous Close

$ 44.5

Open

Bid

$ 44.42 x 107

Ask

$ 44.59 x 100

Day's Range

-- - --

52 Week Range

$ 35.50 - $ 50.93

Volume

49,719

Average Volume

Market Cap

567.73M

Beta (5Y Monthly)

$ 0.90

PE Ratio (TTM)

$ 30.45

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.01)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-01-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	03-01-2024	12-31-2023	10-K
4	11-03-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	03-02-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-05-2022	06-30-2022	10-Q
10	05-06-2022	03-31-2022	10-Q
11	03-04-2022	12-31-2021	10-K
12	11-05-2021	09-30-2021	10-Q
13	08-06-2021	06-30-2021	10-Q
14	05-07-2021	03-31-2021	10-Q
15	03-05-2021	12-31-2020	10-K
16	11-06-2020	09-30-2020	10-Q
17	08-06-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	03-06-2020	12-31-2019	10-K
20	11-07-2019	09-30-2019	10-Q
21	08-07-2019	06-30-2019	10-Q
22	05-08-2019	03-31-2019	10-Q
23	03-07-2019	12-31-2018	10-K
24	11-07-2018	09-30-2018	10-Q
25	08-08-2018	06-30-2018	10-Q
26	05-08-2018	03-31-2018	10-Q
27	03-08-2018	12-31-2017	10-K
28	11-06-2017	09-30-2017	10-Q
29	08-04-2017	06-30-2017	10-Q
30	05-05-2017	03-31-2017	10-Q
31	03-10-2017	12-31-2016	10-K
32	11-04-2016	09-30-2016	10-Q
33	08-05-2016	06-30-2016	10-Q
34	05-06-2016	03-31-2016	10-Q
35	03-10-2016	12-31-2015	10-K
36	11-10-2015	09-30-2015	10-Q
37	08-11-2015	06-30-2015	10-Q
38	05-11-2015	03-31-2015	10-Q
39	03-23-2015	12-31-2014	10-K
40	11-13-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Roth MKM Maintains Buy on iRadimed, Lowers...
08/02/2024 17:04:19

Roth MKM analyst Jason Wittes maintains iRadimed (NASDAQ:IRMD) with a Buy and lowers the price target from $65 to $60.

IRadimed Sees Q3 EPS $0.38-$0.41 Vs $0.37 ...
08/01/2024 12:47:29

"Looking ahead to the year's second half, we are confident in maintaining our strong financial performance. For the thi...

iRadimed Q2 2024 Adj. EPS $0.42 Beats $0.3...
08/01/2024 12:37:14

iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.36 by 16....

IRadimed Announces Uplisting To The Nasdaq...
06/07/2024 12:42:06

IRADIMED CORPORATION ("Iradimed") (NASDAQ:IRMD), a leading provider of innovative magnetic resonance imaging (MRI) comp...

IRADIMED Expects Q2 Adjusted EPS Of $1.52-...
05/02/2024 12:41:09

IRADIMED Expects 2024 Revenues Of $72M-$74...
05/02/2024 12:40:52

IRADIMED Expects Q2 Adjusted EPS Of $0.36 ...
05/02/2024 12:40:43

IRADIMED Expects Q2 Revenues Of $17.6M-$17...
05/02/2024 12:40:35

iRadimed Q1 2024 Adj EPS $0.36 Beats $0.34...
05/02/2024 12:35:18

iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.34 by 5.8...

Roth MKM Reinstates Buy on iRadimed, Annou...
04/22/2024 13:19:59

Roth MKM analyst Jason Wittes reinstates iRadimed (NASDAQ:IRMD) with a Buy and announces $65 price target.

Iradimed Corp Files For Offering Of Common...
04/03/2024 20:30:53

- SEC Filing

IRadimed Forecasts FY24 Revenue of $72M-$7...
02/08/2024 13:10:07

IRadimed Forecasts Q1 FY24 Revenue of $17M...
02/08/2024 13:08:49

iRadimed Q4 Adjusted EPS $0.39 Misses $0.4...
02/08/2024 13:06:40

iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.39 per share which missed the analyst consensus estimate of $0.40 by 2...

Earnings Scheduled For February 8, 2024
02/08/2024 09:43:03

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share ...

iRadimed's Earnings Outlook
02/07/2024 18:02:12

IRADIMED CORPORATION Reports Unaudited Q4 ...
01/09/2024 13:38:37

Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- IRADI...

wednesday-is-your-last-chance-to-buy-iradimed-before-the-dividend-payout

Wednesday Is Your Last Chance To Buy iRadi...
12/18/2023 14:45:20

IRADIMED Sees FY23 Adjusted EPS Of $1.48-$...
11/03/2023 12:09:59

IRADIMED Sees FY23 Revenue Of $65.0M-$65.5...
11/03/2023 12:08:26